Abstract
PEGylation of recombinant proteins and synthetic peptides aims to generate biopharmaceuticals with altered physical properties. The modification may lead to a prolonged serum half-life caused by a decreased receptor-mediated endocytosis and/or a delay in renal clearance caused by the increased hydrodynamic volume of the pharmaceutical. MIRCERA, a PEGylated recombinant erythropoietin (rhEpo) frequently used in the treatment of anemia due to chronic kidney disease, has been also abused by athletes as a performance-enhancing drug. While it can be detected by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting, the sensitivity of the test is significantly lower compared to other epoetins. By replacing SDS with sarcosyl in the sample and running buffers, the interaction between SDS and the PEG group of the protein no longer reduces the affinity of the monoclonal anti-Epo antibody (clone AE7A5) to the protein chain. Contrary to SDS, sarcosyl only binds to the amino acid chain of the PEGylated protein, thus leading to enhanced antibody binding and a sharper electrophoretic band. While the method was originally developed for anti-doping purposes, it may be also useful for other PEGylated proteins and their electrophoretic separation and immunological detection.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
European Medicines Agency (EMEA) (2007) MIRCERA scientific discussion. http://www.emea.europa.eu/humandocs/PDFs/EPAR/mircera/H-739-en6.pdf. Accessed 27 Nov 2009 (document currently no longer accessible), pp 1–4
World Anti-Doping Agency (2009) Harmonization of the method for the identification of recombinant erythropoietins (i.e. epoetins) and analogues (e.g. darbepoetin and methoxypolyethylene glycol-epoetin beta), Montreal. http://www.wada-ama.org/Documents/World_Anti-Doping_Program/WADP-IS-Laboratories/WADA_TD2009EPO_EN.pdf. Accessed 6 Jan 2011
Reichel C, Abzieher F, Geisendorfer T (2009) SARCOSYL-PAGE: a new method for the detection of MIRCERA- and EPO-doping in blood. Drug Test Anal 1:494–504
Invitrogen (2003) NuPAGE technical guide version E (IM-1001). Invitrogen, Carlsbad, p 49
Bjerrum OJ, Schafer-Nielsen C (1986) Buffer systems and transfer parameters for semi-dry electroblotting with horizontal apparatus. In: Dunn MJ (ed) Electrophoresis’86. Wiley-VCH, Weinheim, pp 315–327
Bajla I, Holländer I, Minichmayr M, Gmeiner G, Reichel C (2005) GASepo: a software solution for quantitative analysis of digital images in Epo doping control. Comput Methods Programs Biomed 80:246–270
Lasne F, Martin L, Martin JA, de Ceaurriz J (2007) Isoelectric profiles of human erythropoietin are different in serum and urine. Int J Biol Macromol 41:354–357
MAIIA Diagnostics (2010) Epo purification kit, Upsala. http://www.maiiadiagnostics.com/products/epo_purification_kit/. Accessed 9 Jan 2011
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685
Neville DM Jr (1971) Molecular weight determination of protein-dodecyl sulfate complexes by gel electrophoresis in a discontinuous buffer system. J Biol Chem 246:6328–6334
Allen RC, Moore DJ (1971) Electrophoretic system. US Patent 3620947
Zheng C, Ma G, Su Z (2007) Native PAGE eliminates the problem of PEG-SDS interaction in SDS-PAGE and provides an alternative to HPLC in characterization of protein PEGylation. Electrophoresis 28:2801–2807
Lönnberg M, Dehnes Y, Drevin M, Garle M, Lamon S, Leuenberger N, Quach T, Carlsson J (2010) Rapid affinity purification of erythropoietin from biological samples using disposable monoliths. J Chromatogr A 1217:7031–7037
Dehnes Y, Lamon S, Lönnberg M (2010) Erythropoietin (EPO) immunoaffinity columns: a powerful tool for purifying EPO and its recombinant analogues. J Pharm Biomed Anal 53:1028–1032
Lasne F (2001) Double-blotting: a solution to the problem of non-specific binding of secondary antibodies in immunoblotting procedures. J Immunol Methods 253:125–131
Lasne F (2003) Double-blotting: a solution to the problem of nonspecific binding of secondary antibodies in immunoblotting procedures. J Immunol Methods 276:223–226
Lasne F (2009) Double-blotting: a solution to the problem of nonspecific binding of secondary antibodies in immunoblotting procedures. In: Kurien BT, Scofield RH (eds) Methods in molecular biology, protein blotting and detection, vol 536. Humana Press, New York, p 217
Acknowledgments
This project has been carried out with the financial support of WADA (grant 08B11CR).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Reichel, C. (2012). SARCOSYL-PAGE: A New Electrophoretic Method for the Separation and Immunological Detection of PEGylated Proteins. In: Kurien, B., Scofield, R. (eds) Protein Electrophoresis. Methods in Molecular Biology, vol 869. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-821-4_7
Download citation
DOI: https://doi.org/10.1007/978-1-61779-821-4_7
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61779-820-7
Online ISBN: 978-1-61779-821-4
eBook Packages: Springer Protocols